Together with their general condition, the ratio of sFlt-1/PlGF is an objective factor in the
assessment of suspected preeclampsia. Recent research has shown that the ratio sFlt …

Preeclampsia represents a pregnancy complication characterized by high blood pressure
and proteinuria, after the 20th week of gestation. It appears in 3-5% of pregnant women …

Background and Objectives: Preeclampsia is a health issue characterized by a new onset of
hypertension after 20 weeks of gestation and proteinuria. This is a multiple organ disorder …

Preeclampsia is a major cause of maternal and fetal morbidity and mortality. Early
recognition of the disease may be challenging. Complications may precede the onset of …

Pre-eclampsia is a common and potentially serious disorder of pregnancy. An
antiangiogenic state appears to be central to its development. In particular, the sFlt-1/PlGF …

Objectives Recent studies have shown that inadequate vascularization of the placenta may
be caused by changes in the concentration of anti-angiogenic and pro-angiogenic factors …

Introduction Patients with preeclampsia (PE) exhibit different serum concentrations of sFlt-1
and PlGF. The sFlt-1/PlGF ratio can be used as an aid in the diagnosis of preeclampsia …

Purpose To explore the values of serum sFlt-1, PLGF levels and sFlt-1/PLGF ratio in the
diagnosis and prognosis evaluation of preeclamptic patients. Methods From March 2017 to …

Soluble Fms-like tyrosine kinase 1 (sFlt-1) is an anti-angiogenic factor released in higher
amounts in preeclampsia and implicated in endothelial dysfunction. sFlt-1/PlGF ratio is used …

Objective: To assess the evolution of the sFlt-1/PlGF ratio in women with (suspected)
preeclampsia on clinical grounds. Design and method: sFlt-1 and PlGF serum concentration …